extracorporeal photopheresis with 5-aminolevulinic acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for extracorporeal photopheresis with 5-aminolevulinic acid, covering 2024-01-30 to 2024-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid [Phase 1, Phase 2]